Transcript levels of TGFβ1 receptors (TGFβR1 and TGFβR2), SMAD4 and SMAD7 were examined in CML patients and healthy controls. The gene discussed is SMAD4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.